Free Trial

Capital Research Global Investors Buys 28,968 Shares of Exelon Corporation $EXC

Exelon logo with Utilities background
Image from MarketBeat Media, LLC.

Key Points

  • Capital Research Global Investors increased its stake in Exelon by 0.9%, buying 28,968 shares to hold 3,268,339 shares (about 0.32% of the company) valued at roughly $147.1 million.
  • Exelon raised its quarterly dividend to $0.42 (from $0.40), implying a $1.68 annualized payout and a ~3.4% yield; the record date is March 2 and the payment date is March 13.
  • Exelon beat quarterly EPS estimates ($0.59 vs. $0.55), set FY2026 guidance of $2.810–2.910 EPS (sell‑side consensus ~2.64), and has an average analyst rating of "Hold" with a $50.50 average price target.
  • MarketBeat previews the top five stocks to own by May 1st.

Capital Research Global Investors increased its stake in shares of Exelon Corporation (NASDAQ:EXC - Free Report) by 0.9% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 3,268,339 shares of the company's stock after acquiring an additional 28,968 shares during the period. Capital Research Global Investors owned 0.32% of Exelon worth $147,108,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. LRI Investments LLC boosted its position in Exelon by 210.8% during the third quarter. LRI Investments LLC now owns 578 shares of the company's stock worth $26,000 after purchasing an additional 392 shares during the period. Elevation Point Wealth Partners LLC bought a new position in shares of Exelon in the second quarter valued at approximately $29,000. Root Financial Partners LLC acquired a new stake in shares of Exelon in the third quarter worth $30,000. Steigerwald Gordon & Koch Inc. acquired a new stake in shares of Exelon in the third quarter worth $32,000. Finally, Motco boosted its holdings in shares of Exelon by 1,008.7% during the 3rd quarter. Motco now owns 765 shares of the company's stock worth $34,000 after buying an additional 696 shares during the period. 80.92% of the stock is owned by institutional investors.

Exelon Trading Down 0.3%

Shares of EXC stock opened at $48.84 on Thursday. The firm has a market capitalization of $49.96 billion, a P/E ratio of 17.89, a price-to-earnings-growth ratio of 2.85 and a beta of 0.45. Exelon Corporation has a 1 year low of $41.71 and a 1 year high of $49.88. The firm's fifty day simple moving average is $45.88 and its 200 day simple moving average is $45.35. The company has a current ratio of 0.92, a quick ratio of 0.84 and a debt-to-equity ratio of 1.66.

Exelon (NASDAQ:EXC - Get Free Report) last issued its quarterly earnings results on Thursday, February 12th. The company reported $0.59 earnings per share for the quarter, beating analysts' consensus estimates of $0.55 by $0.04. Exelon had a net margin of 11.41% and a return on equity of 9.97%. The company's revenue was down 1.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.64 earnings per share. Exelon has set its FY 2026 guidance at 2.810-2.910 EPS. As a group, sell-side analysts predict that Exelon Corporation will post 2.64 EPS for the current year.

Exelon Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Investors of record on Monday, March 2nd will be paid a $0.42 dividend. The ex-dividend date is Monday, March 2nd. This is a boost from Exelon's previous quarterly dividend of $0.40. This represents a $1.68 annualized dividend and a dividend yield of 3.4%. Exelon's dividend payout ratio is 61.54%.

Analyst Ratings Changes

A number of research firms recently issued reports on EXC. Jefferies Financial Group lowered their target price on shares of Exelon from $57.00 to $55.00 and set a "buy" rating on the stock in a research note on Tuesday, January 27th. Morgan Stanley restated an "underperform" rating and set a $51.00 price target on shares of Exelon in a report on Wednesday, January 21st. Wolfe Research downgraded Exelon from an "outperform" rating to a "peer perform" rating in a research report on Tuesday, January 27th. UBS Group lifted their price objective on Exelon from $48.00 to $51.00 and gave the stock a "neutral" rating in a research note on Friday, February 20th. Finally, KeyCorp boosted their price objective on Exelon from $39.00 to $44.00 and gave the stock an "underweight" rating in a research report on Wednesday, March 4th. Eight investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $50.50.

Check Out Our Latest Report on Exelon

Exelon Profile

(Free Report)

Exelon Corporation NASDAQ: EXC is a Chicago-based energy company that operates primarily as a regulated electric and natural gas utility holding company. The company's businesses focus on the delivery of electricity and related services to residential, commercial and industrial customers, as well as investments in grid modernization, customer energy solutions and demand-side programs. Exelon's operations emphasize reliable service delivery, infrastructure maintenance and regulatory compliance across its utility footprint.

Formed in 2000 through the merger of Unicom and PECO Energy, Exelon historically combined generation and regulated utility businesses.

Further Reading

Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Corporation (NASDAQ:EXC - Free Report).

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Exelon Right Now?

Before you consider Exelon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.

While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines